Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Alexander

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
The Knee|December 4, 2018
Doctor, when can I drive? - Range of motion of the knee while driving a carDavid Latz, Erik Schiffner, Johannes Schneppendahl, et al.
Journal of Psychopharmacology (Oxford, England)|April 5, 2014
Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approachAmir Inamdar, Emilio Merlo-Pich, Michelle Gee, et al.
Journal of Alzheimer'S Disease : JAD|August 20, 2019
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PF-06751979, a Potent and Selective Oral BACE1 Inhibitor: Results from Phase I Studies in Healthy Adults and Healthy Older SubjectsRuolun Qiu, Jae Eun Ahn, Robert Alexander, et al.
Research Square|July 10, 2026
Microsaccade Dynamics Enhance Nodule Detection and Discriminate Reader Expertise Levels During Chest RadiographySusana Martinez-Conde, Robert Alexander, Stephen Waite, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 18, 2012
Prerequisites to launch neuroprotective trials in Parkinson's disease: an industry perspectiveJohannes R Streffer, Igor D Grachev, Cheryl Fitzer-Attas, et al.
Ecology and Evolution|May 22, 2019
Species sorting and mass effect along forest succession: Evidence from taxonomic, functional, and phylogenetic diversity of amphibian communitiesOmar Hernández-Ordóñez, Bráulio A Santos, Robert Alexander Pyron, et al.
Peerj|March 19, 2019
A new ancient lineage of frog (Anura: Nyctibatrachidae: Astrobatrachinae subfam. nov.) endemic to the Western Ghats of Peninsular IndiaSeenapuram Palaniswamy Vijayakumar, Robert Alexander Pyron, K P Dinesh, et al.
Journal of Psychopharmacology (Oxford, England)|November 4, 2011
Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trialsSusan Learned, Ole Graff, Suraja Roychowdhury, et al.
Sleep|December 3, 2013
Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomniaEmiliangelo Ratti, David J Carpenter, Stefano Zamuner, et al.
Cytokine|October 26, 2007
Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeabilitySwaantje Peters, Ian A Cree, Robert Alexander, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
The Knee|December 4, 2018
Doctor, when can I drive? - Range of motion of the knee while driving a carDavid Latz, Erik Schiffner, Johannes Schneppendahl, et al.
Journal of Psychopharmacology (Oxford, England)|April 5, 2014
Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approachAmir Inamdar, Emilio Merlo-Pich, Michelle Gee, et al.
Journal of Alzheimer'S Disease : JAD|August 20, 2019
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PF-06751979, a Potent and Selective Oral BACE1 Inhibitor: Results from Phase I Studies in Healthy Adults and Healthy Older SubjectsRuolun Qiu, Jae Eun Ahn, Robert Alexander, et al.
Research Square|July 10, 2026
Microsaccade Dynamics Enhance Nodule Detection and Discriminate Reader Expertise Levels During Chest RadiographySusana Martinez-Conde, Robert Alexander, Stephen Waite, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 18, 2012
Prerequisites to launch neuroprotective trials in Parkinson's disease: an industry perspectiveJohannes R Streffer, Igor D Grachev, Cheryl Fitzer-Attas, et al.
Ecology and Evolution|May 22, 2019
Species sorting and mass effect along forest succession: Evidence from taxonomic, functional, and phylogenetic diversity of amphibian communitiesOmar Hernández-Ordóñez, Bráulio A Santos, Robert Alexander Pyron, et al.
Peerj|March 19, 2019
A new ancient lineage of frog (Anura: Nyctibatrachidae: Astrobatrachinae subfam. nov.) endemic to the Western Ghats of Peninsular IndiaSeenapuram Palaniswamy Vijayakumar, Robert Alexander Pyron, K P Dinesh, et al.
Journal of Psychopharmacology (Oxford, England)|November 4, 2011
Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trialsSusan Learned, Ole Graff, Suraja Roychowdhury, et al.
Sleep|December 3, 2013
Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomniaEmiliangelo Ratti, David J Carpenter, Stefano Zamuner, et al.
Cytokine|October 26, 2007
Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeabilitySwaantje Peters, Ian A Cree, Robert Alexander, et al.
Pageof 13